No Data
No Data
A. G. P. Initiates Chromocell Therapeutics(CHRO.US) With Buy Rating, Announces Target Price $8.5
A. G. P. analyst James Molloy initiates coverage on $Chromocell Therapeutics(CHRO.US)$ with a buy rating, and sets the target price at $8.5.According to TipRanks data, the analyst has a success rate o
Alliance Global Partners Initiates Coverage On Chromocell Therapeutics With Buy Rating
Alliance Global Partners analyst James Molloy initiates coverage on Chromocell Therapeutics (AMEX:CHRO) with a Buy rating.
Chromocell Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/18/2024 — Alliance Global Partners Initiates Coverage On → Buy
Express News | Chromocell Therapeutics Corp : Alliance Global Partners Initiates Coverage With Buy Rating; Target Price $8.50
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersInnovative Eyewear (NASDAQ:LUCY) stock increased by 173.2% to $1.12 during Wednesday's regular session. The market value of their outstanding shares is at $19.6 million. Reshape Lifesciences (N
Chromocell Therapeutics | 10-Q: Quarterly report
No Data
i bit the coin 12 : LUV THIS COMPANY , ESPECIALLY THEIR OPIETE'less drugs